High affinity human antibodies to human ILl-4 receptor

Details for Australian Patent Application No. 2007314522 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Pobursky, Kevin J.; Stevens, Sean; Torres, Marcela; Fairhurst, Jeanette L.; Rafique, Ashique; Martin, Joel H.; Papadopoulos, Nicholas J.; Mikulka, Warren R.; Huang, Tammy T.; Ahrens, Diana M.; Windsor, Joan A.; Leidich, Raymond W.; Shi, Ergang

Agent Watermark

Pub. Number AU-A-2007314522

PCT Pub. Number WO2008/054606

Priority 60/848,694 02.10.06 US; 60/957,738 24.08.07 US

Filing date 2 October 2007

Wipo publication date 8 May 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

30 April 2009 PCT application entered the National Phase

  PCT publication WO2008/054606 Priority application(s): WO2008/054606

2 July 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 29 May 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007314524-Differential expression profiling analysis of cell culture phenotypes and the uses thereof

2007314521-Non-nucleoside reverse transcriptase inhibitors